Related Experiment Videos

The Role of NMDA Receptors in Alzheimer's Disease

Jinping Liu1, Lirong Chang2, Yizhi Song2

  • 1School of Medicine, Tsinghua University, Beijing, China.

Frontiers in Neuroscience
|February 26, 2019
PubMed

Insights

Alzheimer

Area of Science:

  • Neuroscience
  • Neurodegenerative Diseases
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) involves early synaptic dysfunction linked to amyloid-beta peptides.
  • Oligomeric amyloid-beta induces NMDAR-dependent synaptic depression and spine loss.
  • Memantine, an NMDAR blocker, is used for moderate to severe AD, but mechanisms require clarification.

Purpose of the Study:

  • To review the role of NMDAR dysfunction in Alzheimer's disease.
  • To explore changes in NMDAR subunit expression in AD.
  • To examine unconventional NMDAR actions in the context of AD.

Main Methods:

  • Literature review of studies on NMDARs and Alzheimer's disease.
  • Analysis of research on amyloid-beta's effects on synaptic function.
  • Examination of NMDAR subunit expression and function in AD models and patients.

Main Results:

  • Oligomeric amyloid-beta disrupts synaptic function via NMDARs.
  • Alterations in NMDAR subunit composition are implicated in AD pathogenesis.
  • NMDARs may exhibit non-canonical functions relevant to AD.

Conclusions:

  • NMDAR dysfunction is a key factor in early Alzheimer's disease.
  • Understanding NMDAR mechanisms offers therapeutic targets for AD.
  • Further research into NMDARs, including unconventional roles, is crucial for AD treatment.

Related Concept Videos